Zoetis ZTS Other developed markets — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zoetis's other developed markets — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zoetis's other developed markets — revenue?
- Zoetis (ZTS) reported other developed markets — revenue of $169M in Q1 2026.
- How has Zoetis's other developed markets — revenue changed year-over-year?
- Zoetis's other developed markets — revenue increased by 27.1% year-over-year, from $133M to $169M.
- What is the long-term trend for Zoetis's other developed markets — revenue?
- Over 4 years (2021 to 2025), Zoetis's other developed markets — revenue has grown at a 8.2% compound annual growth rate (CAGR), from $467M to $641M.
- What does other developed markets — revenue mean?
- This metric represents the total net sales generated from the company's operations within developed geographic regions outside of its primary domestic and major international markets. It captures the financial performance of animal health products, including vaccines, parasiticides, and diagnostics, sold to both companion and production animal customers in these specific territories. Tracking this revenue stream provides insight into the company's global footprint expansion and the adoption rates of its portfolio in mature, non-primary economies.